HK2 and Miyoshi myopathy: Furthermore, in MM, this metabolic reprograming may be induced by the cytokine-induced oncogenic phosphatase PRL-3 through activation of STAT1 and STAT2 transcription factors [204,205] and by cyclin D1 through targeting HK2 [206].